← Leaderboards
Richard Piszczatowski
Albert Einstein College Of Medicine, Inc
$201,096
Attributed
$201,096
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2018–21$100K$75K$50K$25K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$201,096 · 1
By mechanism
F30$201,096 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine, Inc
Same institution · by research overlap
- Meelad Dawlaty$5,115,464
Others in their field
Other Emerging Leaders on “Curative Treatments”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,420,423
- Greg Yothers · University Of Chicago$35,003,821
- Olwen Hahn · Brigham And Women'S Hospital$13,427,021
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$13,240,338
- Barbara Burtness · Yale University$11,604,189
- Angelo A. Cardoso · Beckman Research Institute/City Of Hope$10,820,438
Research focus
Curative TreatmentsAcute Myeloid Leukemia CellAcute Myelocytic LeukemiaApoptosisBaseBcr-Abl Fusion ProteinsAnemiaBlood CellsBlood FormationBone MarrowCaspaseCbl GeneCell Differentiation ProcessCell LineCell LineageBindingCellsCharacteristicsChimeric ProteinsChromosomesChronic Myeloid LeukemiaCo-ImmunoprecipitationsCongenicCytopenia
Grant awards (5)
Investigating the role of Nol3 in normal and malignant hematopoiesis$51,036
F30 · FY2021 · CA · contact PI
Investigating the role of Nol3 in normal and malignant hematopoiesis$50,520
F30 · FY2020 · CA · contact PI
Investigating the role of Nol3 in normal and malignant hematopoiesis$50,016
F30 · FY2019 · CA · contact PI
Investigating the role of Nol3 in normal and malignant hematopoiesis$44,572
F30 · FY2018 · CA · contact PI
Investigating the role of Nol3 in normal and malignant hematopoiesis$4,952
F30 · FY2018 · CA · contact PI